AU2001275004A1 - Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation - Google Patents

Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation

Info

Publication number
AU2001275004A1
AU2001275004A1 AU2001275004A AU7500401A AU2001275004A1 AU 2001275004 A1 AU2001275004 A1 AU 2001275004A1 AU 2001275004 A AU2001275004 A AU 2001275004A AU 7500401 A AU7500401 A AU 7500401A AU 2001275004 A1 AU2001275004 A1 AU 2001275004A1
Authority
AU
Australia
Prior art keywords
exposure
ultraviolet radiation
treating skin
skin injury
cox2 inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275004A
Inventor
Joseph R. Schuh
Karol J. Wilder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia LLC
Original Assignee
Pharmacia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia LLC filed Critical Pharmacia LLC
Publication of AU2001275004A1 publication Critical patent/AU2001275004A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
AU2001275004A 2000-06-01 2001-05-25 Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation Abandoned AU2001275004A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20879800P 2000-06-01 2000-06-01
US60/208,798 2000-06-01
PCT/US2001/017304 WO2001091856A2 (en) 2000-06-01 2001-05-25 Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation

Publications (1)

Publication Number Publication Date
AU2001275004A1 true AU2001275004A1 (en) 2001-12-11

Family

ID=22776106

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275004A Abandoned AU2001275004A1 (en) 2000-06-01 2001-05-25 Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation

Country Status (3)

Country Link
US (1) US20020009421A1 (en)
AU (1) AU2001275004A1 (en)
WO (1) WO2001091856A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035139A1 (en) * 2000-06-20 2002-03-21 Herbst Arthur L. COX-2 inhibitors and the prevention of the side effects of radiation therapy
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
ES2213485B1 (en) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. DERIVATIVES OF 2-FENILPIRAN-4-ONA.
ES2214130B1 (en) * 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 2-3'-BIPIRIDINES.
US20040214861A1 (en) * 2003-03-28 2004-10-28 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitors and 5-HT1B1D antagonists for the treatment and prevention of migraine
US20040224940A1 (en) * 2003-04-22 2004-11-11 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of central nervous system damage

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954332A (en) * 1987-10-22 1990-09-04 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation
ATE223390T1 (en) * 1995-02-13 2002-09-15 Searle & Co SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION
EP1977749A1 (en) * 1996-10-15 2008-10-08 G.D. Searle LLC Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
US5972986A (en) * 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
CA2348979A1 (en) * 1998-11-02 2000-05-11 Merck & Co., Inc. Method of treating migraines and pharmaceutical compositions
SA99191255B1 (en) * 1998-11-30 2006-11-25 جي دي سيرل اند كو celecoxib compounds
ES2249253T3 (en) * 1999-03-10 2006-04-01 G.D. Searle Llc METHOD AND COMPOSITION TO ADMINISTER A CYCLLOXYGENASA-2 INHIBITOR.

Also Published As

Publication number Publication date
WO2001091856A3 (en) 2002-12-27
WO2001091856A2 (en) 2001-12-06
US20020009421A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
IL161775A0 (en) Topical compositions and methods for treatment of adverse effects ofionizing radiation
HUP0201393A3 (en) Use of xenon for treating neurointoxications
DE60014873D1 (en) SYNERGISTIC COMPOSITIONS FOR TREATMENT OF CANCER
NO20015112L (en) Use of glycosylceramide synthesis inhibitors in therapy
AU2003301111A8 (en) Apparatus for light treatment of acne and other disorders of follicles
EP1267798A4 (en) Treatment of skin damage using polyenylphosphatidylcholine
IL149070A0 (en) Apparatus and method for targeted uv phototherapy of skin disorders
HUP0204182A3 (en) Use of fumaric acid derivatives for treating mitochondrial diseases
EP1663104A4 (en) Porifera-based therapeutic compositions for treating and preventing skin diseases
EP1402068A4 (en) Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
AU2003276607A1 (en) A device for treating human skin by means of radiation
PT1282616E (en) DERIVATIVES OF HYDROXYPHENYL-PIPERIDIN-4-ILIDENE-METHYL-BENZAMIDE FOR TREATMENT
AU5160201A (en) Compositions comprising natural agents for treatment of cancer
HUP0201187A2 (en) Use of ecteinascidin743 for producing pharmaceutical compositions suitable for treating cancer
EP1379242A4 (en) Method for treatment of cancer and compositions for use therein
AU2003274590A1 (en) Device for treating human skin by means of radiation
IL161059A0 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
AU2001268233A1 (en) Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
EP1359885A4 (en) Nos inhibitors for treatment of wrinkles
AU2001275004A1 (en) Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation
GB0126662D0 (en) Treatment of skin using laser radiation
IL129705A (en) Use of selected benzotriazole derivatives for protecting human and animal skin and hair from the harmful effects of uv radiation
HUP0302430A3 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience
AU2003251407A8 (en) Topical treatment for skin irritation
AU2003241346A8 (en) Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer